A Market Worth Understanding

The US pharmacy market generates over $550 billion in annual revenue and touches nearly every American household. With roughly 88,000 pharmacy locations across the country — from national chains to independent shops — the industry represents one of the most geographically distributed retail networks in existence. For healthcare companies, pharmaceutical manufacturers, and investors, understanding this market through data is not optional. It is foundational.

The Big Three: CVS, Walgreens, and Rite Aid

Three chains have historically dominated the US pharmacy landscape, though their trajectories have diverged sharply in recent years.

CVS Health operates approximately 9,000 retail pharmacy locations nationwide and fills roughly 1.4 billion prescriptions annually. CVS has aggressively diversified beyond traditional pharmacy retail, acquiring Aetna in 2018 and expanding its MinuteClinic and HealthHUB concepts. Their store footprint provides coverage in 49 states, with particularly strong density in the Northeast and Mid-Atlantic regions.

Walgreens Boots Alliance runs about 8,600 US locations, making it the second-largest pharmacy chain by store count. Walgreens has historically been strongest in urban and suburban markets, with notable density in the Midwest and Southeast. The company has faced significant headwinds in recent years, closing hundreds of underperforming locations while investing in its VillageMD primary care clinics.

Rite Aid, once the third pillar of US pharmacy retail, has undergone dramatic contraction. After filing for bankruptcy in 2023, the chain reduced its footprint from roughly 2,400 stores to under 1,400. Rite Aid's remaining presence is concentrated in the Northeast and West Coast, leaving significant market gaps that competitors are racing to fill.

Geographic Coverage and Market Gaps

Scraping store locator data from pharmacy chains reveals patterns that are not obvious from headline numbers alone. When you map every pharmacy location in the US, clear geographic patterns emerge:

• Urban saturation: In major metro areas, CVS and Walgreens locations are often within a few blocks of each other, creating intense local competition. Manhattan, for instance, has roughly one pharmacy for every 2,500 residents.
• Rural deserts: Rural counties frequently have just one or two pharmacy options, often an independent pharmacy or a Walmart pharmacy inside a Supercenter. Over 4,000 US communities are classified as pharmacy deserts, where residents must travel 10+ miles to reach a pharmacy.
• Rite Aid gaps: The Rite Aid contraction has created specific geographic opportunities. Scraping their closed-store addresses and cross-referencing with competitor locations reveals underserved areas where demand still exists.

For healthcare companies evaluating market entry, distribution partnerships, or service coverage, this geographic data is invaluable.

Market Share Beyond Store Count

Store count alone does not tell the full market share story. Scraping prescription volume data, revenue estimates, and customer traffic indicators provides a more nuanced picture:

• CVS commands roughly 26% of the US retail pharmacy market by prescription revenue
• Walgreens holds approximately 20%
• Walmart Pharmacy, with about 4,600 in-store locations, captures roughly 6%
• Amazon Pharmacy and mail-order services are growing rapidly, capturing an estimated 4-5% and accelerating
• Independent pharmacies, numbering around 19,000, collectively hold about 35% of the market

The rise of mail-order and digital pharmacy services is reshaping market dynamics. Scraping prescription pricing from Amazon Pharmacy, Cost Plus Drugs, and other digital-first players reveals pricing pressure that traditional chains must respond to.

Prescription vs OTC Trends

The pharmacy market is essentially two businesses under one roof: prescription medications and over-the-counter (OTC) retail products. Data scraping reveals diverging trends in these segments.

Prescription trends: Specialty medications now account for over 50% of pharmacy spending despite representing only 2% of prescriptions filled. GLP-1 drugs (Ozempic, Wegovy, Mounjaro) have become a massive revenue driver, with scraping data showing significant pharmacy-to-pharmacy price variation. Generic medication dispensing remains the volume driver, with generics representing roughly 90% of prescriptions filled.

OTC trends: Scraping product catalog data shows pharmacy chains are expanding their health and wellness offerings, adding supplements, home diagnostics, and personal care products. CVS in particular has restructured its front-of-store layout around health categories. Price comparison scraping shows that OTC pricing varies by 15-40% across pharmacy chains for identical products — a gap that informed consumers are increasingly exploiting through comparison tools.

How Scraping Pharmacy Data Supports Healthcare Decisions

Healthcare companies and pharmaceutical manufacturers use pharmacy data scraping in several practical ways:

Drug pricing intelligence: By scraping cash prices, insurance copays, and discount program prices (GoodRx, RxSaver) across pharmacy chains, pharmaceutical companies can monitor how their products are priced at the retail level and identify unauthorized price discounting.

Distribution coverage analysis: Scraping pharmacy inventory data and product availability helps manufacturers understand where their products are actually stocked versus where distribution agreements suggest they should be.

Competitive product monitoring: When a competitor launches a new OTC product or generic medication, scraping pharmacy product pages provides real-time visibility into pricing, placement, and availability across major chains.

Patient access mapping: Healthcare companies use pharmacy location data combined with demographic and health outcome data to identify communities with limited access to specific medication categories or health services.

Market trend detection: Scraping pharmacy search trends, product reviews, and stock status signals across major chains provides early indicators of demand shifts — whether driven by seasonal illness, new drug approvals, or emerging health concerns.

A Data-Rich Industry

The US pharmacy market sits at the intersection of healthcare, retail, and technology — three sectors that generate enormous amounts of publicly available data. For organizations willing to invest in systematic data collection, the pharmacy market offers rich opportunities to build competitive intelligence, inform strategic decisions, and identify market gaps before competitors do.

Whether you are tracking drug pricing across pharmacy chains or mapping geographic coverage gaps, contact ScrapeAny to learn how our data extraction services can support your healthcare market intelligence needs.